Novavax

  • Thailand

    200,000 Covovax vaccines from India expected to arrive in Thailand today

    The Ministry of Public Health reports that Thailand will receive 200,000 Covovax vaccines from India today. Public Health Minister, Anutin Charnvirakul, will be on call to receive the vaccine delivery personally. The Director-General of the Disease Control Department, Dr. Opas Kankawinpong says that the Covovax vaccines were donated by the QUAD, or the countries that agreed on Quadrilateral Security Dialogue…

  • Coronavirus (Covid-19)

    FDA approves protein-based Covovax vaccine for emergency use in Thailand

    Need a Covid jab? If you’re in Thailand, you’ll have a new option. The Food and Drug Administration has approved the protein-based Covovax vaccine manufactured by Novavax for active immunisation against Covid-19. The FDA granted the vaccine emergency-use authorisation for individuals 18 years of age and older last Friday, according to a press release from Novavax. The vaccine — known…

  • Coronavirus World

    European regulators approve Novavax Covid-19 vaccine

    European regulators have approved the Novavax Covid-19 vaccine after months of delays. The protein-based vaccine takes a similar approach to that of vaccines long deployed against meningitis, hepatitis, and other illnesses. It provides European countries with another weapon in the fight against Covid-19, but according to a Bloomberg report, its efficacy against the newly-emerged Omicron variant is not yet known.…

  • Indonesia

    Indonesia approves Novavax Covid-19 vaccine for emergency use

    The Indonesian government has approved the Novavax Covid-19 vaccine for emergency use, the first country in the world to do so. The Bangkok Post reports that the manufacturer and its partner, Serum Institute of India, has confirmed the approval. The vaccine will be sold under the brand name Covovax. The manufacturers have applied for emergency use authorisation in several countries,…

  • World

    Novavax says vaccine 100% effective at preventing severe illness, hospitalisation

    The US firm Novavax says trials on its Covid-19 vaccine have shown it to be 100% effective at preventing serious illness, hospitalisation or death from the virus. However, the efficacy rate fell sharply against mild to moderate cases of the South African variant. The Bangkok Post reports that one phase 3 trial took place in the UK and included 15,000…